ENZYME INHIBITORS
    5.
    发明申请
    ENZYME INHIBITORS 审中-公开
    酶抑制剂

    公开(公告)号:US20140155439A1

    公开(公告)日:2014-06-05

    申请号:US14175072

    申请日:2014-02-07

    IPC分类号: C07D213/56 C07C237/20

    摘要: Compounds of formula (I), inhibit HDAC activity: wherein A, B and D independently represent ═CH— or ═N—; W is —CH═CH— Or —CH2CH2—; R1 is a carboxylic acid group (—COOH), or an ester group which is hydrolysable by one or more intracellular carboxylesterase enzymes to a carboxylic acid group; R2 and R3 are selected from the side chains of a natural or non-natural alpha amino acid, provided that neither R2 nor R3 is hydrogen, or R2 and R3, taken together with the carbon to which they are attached, form a 3-6 membered saturated cycloalkyl or heterocyclyl ring; Y is a bond, —C(C═O)—, —S(═O)2—, —C(C═O)O—, —C(C═O)NR′—, —C(═S)—NR′, —C(═NH)NR′ or —S(═O)2NR— wherein R′ is hydrogen or optionally substituted C1-C6 alkyl; L1 is a divalent radical of formula -(Alk1)m(Q)(Alk2)p— wherein in, n, p, Q, AIk1 and AIk2 are as defined in the claims; X1 represents a bond; —C(═O); or —S(═O)2—; —NR4C(═O)—, —C(C═O)NR4—, —NR4C(═O)NR5—, —NR4S(═O)2—, or —S(═O)2NR4— wherein R4 and R5 are independently hydrogen or optionally substituted C1-C6 alkyl; and z is 0 or 1.

    摘要翻译: 式(I)化合物抑制HDAC活性:其中A,B和D独立地表示= CH-或= N-; W是-CH = CH-或-CH 2 CH 2 - ; R1是羧酸基团(-COOH)或可被一个或多个细胞内羧酸酯酶水解成羧酸基团的酯基; R2和R3选自天然或非天然α氨基酸的侧链,条件是R2和R3都不是氢,或者R2和R3与它们所连接的碳一起形成3-6 元环饱和环烷基或杂环基环; Y是键,-C(= O) - , - S(= O)2 - , - C(C = O)O-,-C(C = O)NR' - , - -NR',-C(= NH)NR'或-S(= O)2 NR-,其中R'是氢或任选取代的C 1 -C 6烷基; L1是式 - (Alk1)m(Q)(Alk2)p的二价基团,其中n,n,p,Q,Alk1和Alk2如权利要求中所定义; X1表示键; -C(= O); 或-S(= O)2 - ; -NR 4 C(= O) - , - C(C = O)NR 4 - ,-NR 4 C(= O)NR 5 - ,-NR 4 S(= O)2 - 或-S(= O)2 NR 4 - 独立地是氢或任选取代的C 1 -C 6烷基; z为0或1。